The process typically involves the patient's physician submitting a request to the FDA, which includes detailed medical information about the patient, the proposed treatment plan, and scientific rationale for the use of the investigational product. The FDA reviews this information and decides whether to grant access. The pharmaceutical company that manufactures the investigational product must also agree to provide it.